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ABSTRACT We assessed the practicality of using the transfusion Basic Information Sheet (BIS) for data collection, to 
determine the overall adequacy of physician documentation of blood product transfusion, and to make an audit of 
the appropriateness of blood product transfusion. The transfusion process and clinical indications for transfusions 
administered to adult hospitalized patients in 3 tertiary care teaching hospitals in Qazvin were prospectively 
reviewed. Adequate documentation was achieved in 62.6% of all transfusion episodes, range 41%–73%, depending 
on the medical specialty; 15.7% of red blood cells and whole blood requests, 40.8% of platelet requests and 34.1% 
of fresh frozen plasma requests were inappropriate. BIS-based information along with data collection can be used 
to provide feedback regarding the effectiveness of and compliance with local and national transfusion guidelines. 
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 ةحصلا  ةمظنلم  ةيساسلأا  تامولعلما  ةحيفص مادختساب  ةيملاسلإا ناريإ  ةيروهجم ،نيوزق  في مدلا  تاجتنم  لقن  لىع شيتفتلا
 ةيلماعلا
يدممح ديون ،اهوللا ةمطاف ،دباع حلاف زيورب ،ينك ايلماك ،يملاسلإا خيش نوياهم
 ف ُّرعتلاو ،تايطعلما عجم في قيبطتلل ةيلباق نم مدلا لقن لوح ةيساسلأا تامولعلما ةحيفص هب عَّتمتت ام ىدم مييقت ةساردلا هذه تفدهتسا :ةـصلالخا
 عجار دقو .ةحيفصلا هذه مادختساب مدلا تاجتنم لقن ةمءلام ىدم لىع شيتفتلا ذيفنت مث ،مدلا تاجتنم لقنل ءابطلأا قيثوتل ةيلاجملإا ةيافكلا لىع
 في  ةيثلاثلا  ةياعرلل  ةيميلعتلا  تايفشتسلما  اولخدأ  نيذلا  ينغلابلا  ىدل  اله  ةيريسرلا  يعاودلاو  مدلا  تاجتنم  لقن  َةيلمع  ةيقابتسا  ةعجارم  نوثحابلا
 نم %62.6 ىدل ق َّقتح دق فياكلا قيثوتلا نأ لاجملإا هجو لىع نوثحابلا دجو دقو .مدلا لقن لوح ةيساسلأا تامولعلما ةفيحص اومدختساو ،نيوزق
 %15.7 ىدل ةمئلام نكت لم لقنلا تابلط نأ نوثحابلا دجو ماك .يبطلا صاصتخلال ًاعبت كلذو ،%73و %41 ينب حوارـتي ىدمبو ،مدلا لقن تا َّرم عيجم
 نوثحابلا جتنتساو .ةدمجلما امزلابلا لقن تابلط نم %34.1و تاحيفصلا لقن تابلط نم %40.8و ،مدلا لماكو ءارملحا تايركلا لقن تابلط نم
 لئلادلا ةيلاعف لوح ةيعاتجرا تامولعم ميدقت فدبه تايطعلما عجم عم ةيساسلأا تامولعلما ةحيفص لىع ةزكترلما تامولعلما مادختسا نكملما نم نأ
.اله لاثتملاا ىدم لوحو مدلا لقنل ةينطولاو ةيلحلما ةيداشرلإا
Audit de la transfusion des produits sanguins à l’aide de la fiche d’information de base de l’Organisation 
mondiale de la Santé, à Qazvin (République islamique d’Iran)
RÉSUMÉ Nous avons évalué l’aspect pratique de l’utilisation de la fiche d’information de base relative à la 
transfusion et destinée au recueil des données, de déterminer l’adéquation générale de la documentation 
des médecins sur la transfusion des produits sanguins, et de conduire un audit sur la pertinence des épisodes 
de transfusion. Le processus de transfusion et les indications cliniques de transfusions sanguines administrées 
aux patients adultes hospitalisés dans trois hôpitaux universitaires de soins tertiaires à Qazvin ont été étudiés 
prospectivement. Globalement, une documentation adéquate a été obtenue dans 62,6 % des épisodes de 
transfusion. Ce pourcentage variait de 41 % à 73 % selon les spécialités médicales. Nous avons observé que 15,7 % 
des demandes de transfusion d’érythrocytes et de sang total, 40,8 % des demandes de plaquettes et 34,1 % des 
demandes de plasma frais congelé étaient contre-indiquées. Les données recueillies sur la fiche d’information 
de base associées aux autres données collectées peuvent être utilisées pour analyser l’utilisation efficace et 
conforme des directives nationales et locales des pratiques de transfusion.


















sion  is  considered  appropriate when 
it  is used to  treat conditions  leading  to 
significant morbidity and mortality and 
which cannot be prevented or managed 










tem  using  a  basic  information  sheet 
(BIS)  to  improve  the  clinical  use  of 
blood products. The outcome of  the 























blood  cell  (RBC),  platelet,  and  fresh 
frozen  plasma  (FFP)  transfusions 










FFP  transfusions was  assessed  using 
the  recommendations  published  by 
the British Committee  for Standards 
in Haematology  (BCSH)  [6,7],  and 
RBC  transfusions were  reviewed and 












The  following  information  was 
documented  through  a  customized 
BIS  for  transfusion [5] (Farsi  version, 
translated by a haematologist native  to 











and/or  laboratory  improvement),  and 
transfusion side-effects [5]. 
Documentation  adequacy  was 
judged  independent of  transfusion  jus-
tification. Transfusions were classified 

































fusion  episode  information  for  each 
department are shown in Table 1.
Of 829  transfusion  episodes,  519 
















Adequate  documentation  of  patient 
identification  required  that  patient’s 
name,  age,  sex,  and weight were com-





















ence  of  shock  and  the  International 








the  clinicians  indicated  that  they had 
achieved  the  laboratory  improvement, 
a  review of outcome  indicators  com-














of  763  blood  product  transfusions, 
79.6% were judged appropriate. 
Table 1 Patient demographic data and transfusion episode information according to department








Males, No. (%) 234 (60) 107 (67) – 341 (46)
Females, No. (%) 156 (40) 53 (33) 192 (100) 401 (54)
Mean (SD) age (years) 56.7 (19.9) 50.5 (23.7) 33.4 (9.6) 49.6 (21.2)
No. of transfusion episodes
WB 19 15 58 92
RBC 281 147 109 537
PC 67 2 18 87
FFP 78 3 32 113
Total 445 167 217 829
Units/episode,  
mean (SD) median [range]
WB 2.1 (1.4) 2 [1–7] 1.6 (1.1) 1 [1–4] 1.7 (0.9) 2 [1–6] 1.8 (1.0) 2 [1–7]
RBC 1.6 (0.6) 2 [1–4] 1.8 (0.8) 2 [1–4] 1.8 (0.9) 2 [1–4] 1.7 (0.7) 2 [1–4]
PC 7.5 (2.5) 7 [2–10] 6.0 (6)a 4.9 (2.5) 4 [2–10] 6.9 (2.6) 6 [2–10]
FFP 2.8 (1.7) 2 [1–10] 2.0 (2) a 2.9 (1.6) 2 [2–9] 2.8 (1.7) 2 [1–10]
No. of units transfused
WB 42 24 102 168
RBC 461 258 193 912
PC 500 12 88 600
FFP 215 6 93 314
Total 1218 300 476 1994
Single unit transfusions
RBC, No. (%) 119 (42.3) 53 (36.8) 51 (46.4) 223 (49.9)
WB, No. (%) 7 (35) 10 (66.7) 23 (39.7) 40 (45.2)
aThere was only 1 episode of PC transfusion and 1 episode of FFP transfusion in the Department of Surgery, thus, there is no standard deviation or range.  
SD = standard deviation; WB = whole blood; RBC = red blood cells; PC = platelet concentrate; FFP = fresh frozen platelets.




Several  lines of  research have emerged 
that  suggest  the use of  the  transfusion 
BIS  promotes  self  education  in  new 












mentation  (at  least  documentation 
of  a  reason  for  transfusion,  pre-  and 
post-transfusion clinical or  laboratory 









as  accurately  and  completely  as pos-










the  clinicians  indicated  that  they had 
achieved  their  laboratory  results,  but 
in only 33.6% did they meet the actual 
endpoints, while not inconsistent with 
WHO  findings  [5],  is  striking,  and 
highlights  the  discrepancy  between 
clinicians’  statements  and actual per-
formance. The  study  results  showed 
that  there was a significant correlation 
between this finding and inappropriate 
use within  established  clinical  guide-
lines.







commencing  treatment.  Including  the 




than  global  assessment of  shock  and 
leads to improved documentation.
Moreover,   in  agreement  with 
results  of  previous  reports  [5,8],  the 
ICD10 code was often not  recorded, 
probably because  it was  seldom avail-
able  for  the  clinicians  at  the  bedside 
practice. Therefore  the  ICD10  code 
could be  removed  and  replaced with 
Table 2 Number and percentages of transfusion episodes with adequate documentation in each part of the basic information 
sheet (BIS) and overall adequate documentation according to department
Section of the transfusion BIS Department
Internal medicine Surgery Obstetrics & 
gynaecology
Total 
(n = 445) (n = 167) (n = 217) (n = 829)
No. % No. % No. % No. %
Patient identification 295 66.2 112 66.9 129 59.4 536 64.6
Start of transfusion 316 71.0 139 83.1 177 81.6 596 76.2
Assessment
Pre-transfusion 432 97.1 158 94.6 209 96.3 799 96.3
Post-transfusion 366 82.2 139 83.1 116 53.4 621 74.9
Transfusion targets 387 86.9 156 93.4 187 86.1 730 88.1
Outcome 383 86.1 143 85.5 137 63.1 663 80.0
Overalla 307 69.2 121 72.3 91 41.9 519 62.6
Outcome of transfusion therapy (n = 383) (n = 143) (n = 137) (n = 663)
Improvement 325 84.8 133 93.0 127 92.7 585 88.2
Both clinical & laboratory 
improvement 199 51.9 83 58.0 65 47.4 347 54.9
Clinical improvement 95 26.4 50 34.9 51 37.2 196 29.7
Laboratory improvement 31 8.1 0 0.0 11 8.0 42 6.3
Either clinical or laboratory 
improvement 126 32.9 50 34.9 62 45.3 238 35.9
No improvement 58 15.1 10 6.9 10 7.3 78 11.7
aAdequate documentation included at least a plan for transfusion, pre- and post-transfusion clinical or laboratory assessment, and outcome of transfusion.
















ations  in which  the  transfusions were 
considered inappropriate, the audit data 
using the WHO BIS showed that 15.7% 
of  RBC  and  whole  blood  requests, 
40.8% of platelet  requests,  and 34.1% 
of  FFP  requests, were  inappropriate. 
The rate of  inappropriate use of RBC, 
platelet, and FFP was within the ranges 
reported  in previous  studies  [11–16]. 
However,  our  results  are not directly 
comparable with  these  results because 
of differences in the guidelines used.









by  itself,  however,  its  use without  an 





Table 3 Appropriate and inappropriate blood products transfused according to hospital guidelines for red blood cell 
transfusions and according to British Committee for Standards in Haematology (BCSH) guidelines for platelet and fresh 
frozen platelet (FFP) transfusions [6,7]
Indication Appropriate episodes Inappropriate episodes 
No. (sum of units 
transfused)
Mean (SD) range No. (sum of units 
transfused)
Mean (SD) range
Contributory indications for RBC according to   
 hospital guidelines (WB, RBC) (n = 596) 503 (881) 1.8 (0.82) 1–7 93 (142) 1.5 (0.63) 1–4
Acute blood lossa 176 (337) 1.9 (0.78) 1–4 35 (55) 1.6 (0.60, 1–4
Anaemia in critical care (target values as for acute   
 blood loss) 64 (107) 1.7 (1.10) 1–6 9 (12) 1.3 (1.0) 1–4
Peri-operative transfusion (to maintain Hb   
 concentration > 10g/dL) 82 (128) 1.6 (0.65) 1–4 24 (35) 1.4 (0.52) 1–2
Anaemiab 145 (256) 1.7 (0.72) 1–4 11 (18) 1.6 (0.87) 1–4
Anaemiac 36 (53) 1.4 (0.51) 1–2 14 (22) 1.5 (0.75) 1–4
Contributory indications for platelets (n = 76) 45 (327) 7.4 (2.6) 2–10 31 (201) 6.4 (2.7) 2–10
Bone marrow failured 27 (208) 8.0 (2.2) 3–10 6 (47) 7.8 (2.7) 4–10
Peri-operative or invasive proceduree 11 (69) 8.0 (2.2) 3–10 7 (41) 5.8 (2.0) 4–10
Massive haemorrhage/transfusionf 1 (10) 10.0g 5 (20) 4.0 (1.8) 2–6
Acute DIC in presence of bleeding & severe   
 thrombocytopenia 1 (10) 10.0 2 (10) 5.0 (0.0) 5
Autoimmune thrombocytopenia in presence of   
 major haemorrhage 5 (30) 6.0 (3.8) 2–10 11 (83) 7.5 (2.8) 3–10
Contributory indications for FFP (n = 91) 60 (172) 2.8 (1.4) 1–10 31 (71) 2.3 (1.7) 1–6
Single factor or coagulation inhibitor deficiency 5 (17) 3.4 (0.54) 3–4 – –
Immediate reversal of warfarin effect in presence  
 of life-threatening bleeding 10 (34) 3.4 (2.5) 1–10 9 (22) 2.4 (0.8) 1–4
Acute DIC in presence of bleeding and abnormal   
 coagulation results 16 (53) 3.3 (1.4) 2–7 10 (21) 2.1 (1.2) 1–5
Liver disease 14 (31) 2.2 (0.80) 1–3 6 (18) 3.0 (2.0) 1–6
Active bleeding and PT > 1.5 × mean normal value 15 (37) 2.5 (0.64) 2–4 6 (10) 1.7 (0.51) 1–2
aTo maintain circulating blood volume and Hb concentration > 8g/dL in otherwise fit patients and > 10g/dL in elderly patients and those with known cardiovascular and 
respiratory diseases. 
bHb concentration < 8g/dL in otherwise fit patients. 
cHb concentration < 10g/dL in patients over 65 years and patients with cardiovascular or respiratory disease. 
dTo prevent spontaneous bleeding when the platelet count < 10 × 109/L or < 20 × 109/L in the presence of additional risk factors for bleeding. 
ePlatelet count < 50 × 109/L, or < 100 × 109/L before surgery in critical sites such as brain or eyes. 
fPlatelet count < 50, or < 100 × 109/L if micro-vascular oozing. 
gThere was only 1 episode of 10 units PLT transfusion, thus, there is no standard deviation or range. 
WB = whole blood; RBC = red blood cells; SD = standard deviation; Hb = haemoglobin; PT = prothrombin time; DIC = disseminated intravascular coagulation.





















nents  against  transfusion  guidelines. 







is  provided prior  to prescription  and 
administration of  blood,  and  the pa-
tient receives the correct blood product 
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that may influence the transfusion deci-
sion could also be included.
In  conclusion,  the  study  findings 
suggest that the WHO BIS would be a 
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